XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Consolidated Statements of Operations [Abstract]      
Net sales $ 757,354,000 $ 717,684,000 $ 683,074,000
Cost of goods sold 603,526,000 585,133,000 569,112,000
Gross profit 153,828,000 132,551,000 113,962,000
Operating expenses:      
General and administrative 64,047,000 57,769,000 54,756,000
Sales and marketing 22,561,000 22,481,000 21,729,000
Research and development 11,405,000 9,995,000 10,322,000
Foreign exchange impact of lease liabilities and forward contracts 15,892,000 (3,814,000) (9,291,000)
Total operating expenses 113,905,000 86,431,000 77,516,000
Operating income 39,923,000 46,120,000 36,446,000
Other expenses:      
Interest expense, net 55,550,000 60,040,000 39,555,000
Change in fair value of compound net derivative liability 60,000 (1,020,000) 0
Loss on extinguishment of debt 0 168,000 0
Total other expenses 55,610,000 59,188,000 39,555,000
Loss before income tax expense (15,687,000) (13,068,000) (3,109,000)
Income tax expense 3,783,000 36,176,000 1,098,000
Net loss $ (19,470,000) $ (49,244,000) $ (4,207,000)
Basic net loss per share (in Dollars per share) $ (0.99) $ (2.51) $ (0.22)
Diluted net loss per share (in Dollars per share) $ (0.99) $ (2.51) $ (0.22)
Weighted average number of shares outstanding:      
Basic (in Shares) 19,685,322 19,601,204 19,340,246
Diluted (in Shares) 19,685,322 19,601,204 19,340,246